Financial Enhancement Group’s Idexx Laboratories IDXX Stock Holding History

Financial Enhancement Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3	Closed	-$1K	–	210
2022 Q3	$1K	Sell	3 -16	-84%	-$5.88K	﹤0.01%	275
2022 Q2	$7K	Sell	19 -1	-5%	-$408	﹤0.01%	197
2022 Q1	$11K	Sell	20 -3	-13%	-$1.58K	﹤0.01%	187
2021 Q4	$15K	Hold	23	–	–	﹤0.01%	177
2021 Q3	$14K	Sell	23 -7	-23%	-$4.7K	﹤0.01%	182
2021 Q2	$19K	Hold	30	–	–	﹤0.01%	163
2021 Q1	$15K	Hold	30	–	–	﹤0.01%	162
2020 Q4	$15K	Hold	30	–	–	﹤0.01%	188
2020 Q3	$12K	Sell	30 -5,096	-99%	-$1.88M	﹤0.01%	166
2020 Q2	$1.69M	Buy	5,126 +5,088	+13,389%	+$1.47M	0.43%	42
2020 Q1	$9K	Sell	38 -2	-5%	-$522	﹤0.01%	200
2019 Q4	$10K	Hold	40	–	–	﹤0.01%	195
2019 Q3	$11K	Hold	40	–	–	﹤0.01%	195
2019 Q2	$11K	Hold	40	–	–	﹤0.01%	188
2019 Q1	$9K	Sell	40 -36	-47%	-$7.43K	﹤0.01%	223
2018 Q4	$19K	Hold	76	–	–	0.01%	162
2018 Q3	$19K	Hold	76	–	–	0.01%	162
2018 Q2	$17K	Hold	76	–	–	0.01%	158
2018 Q1	$15K	Buy	+76	New	+$14K	0.01%	169

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Financial Enhancement Group's IDXX Position: Q4 2022 in Review

Financial Enhancement Group sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 3 shares — an estimated $1K sold.

Financial Enhancement Group first reported a position in IDXX in Q1 2018 and held it in 19 quarters. The position peaked at $1.69M in Q2 2020. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

Financial Enhancement Group reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
Financial Enhancement Group sold 3 Idexx Laboratories shares in Q4 2022, an estimated $1K.
Financial Enhancement Group first reported a position in Idexx Laboratories in Q1 2018 and held it in 19 quarters.
Financial Enhancement Group's Idexx Laboratories position peaked at $1.69M in Q2 2020.
999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.